You can use the -k command line option to specify an expressionwhich implements a substring match on the test names instead of theexact match on markers that -m provides. This makes it easy toselect tests based on their names:
markers
Plugins can provide custom markers and implement specific behaviourbased on it. This is a self-contained example which adds a commandline option and a parametrized test function marker to run testsspecified via named environments:
If you are heavily using markers in your test suite you may encounter the case where a marker is applied several times to a test function. From plugincode you can read over all such settings. Example:
For 2022, marker applications shall continue to be accepted and processed for approval by the Vermont State Historic Preservation Officer and Advisory Council on Historic Preservation. However, due to unforeseen delays at the Foundry, no markers shall be produced for the remainder of this year. For expected 2023 dedications, please contact ACCD.historicmarkers@vermont.gov to discuss production limitations.
If you wish to report a missing or damaged marker, please email Jennifer Lavoie at ACCD.historicmarkers@vermont.gov. Please let us know the name of the marker, location, and when you first noticed it was missing or damaged.
Besides standard markers, pose markers are another type of markers,which are specific to armatures and shape keys.They are used to denote poses in the Action Editor mode and Shape Keys Editor of Dope Sheet.
Regular markers are shown as small white triangles, empty if unselected or filled if selected,and with a dashed line that covers the editor height at the corresponding frame.If they have a name, this is shown to their right in white.
In the Graph Editor, Dope Sheet, NLA Editor, Timeline, and Video Sequence Editor,you can also select all markers with A while hovering the mouse over the marker row,and apply selection tools on them like Box Select, etc.(as usual, LMB to select, RMB to deselect).The corresponding options are found in the Select menu of these editors.
Once you have one or more markers selected, press G,while hovering with the mouse over the marker bar,to move them, and confirm the move with LMB or Return(as usual, cancel the move with RMB, or Esc).Or drag them with the LMB.
To use this operator, select the object to become the active cameraand select a marker to bind the active camera to.If no marker is selected when the operator is applied, a marker will be added.When an object is bound to a marker, the marker will be renamed to the name of the active object.These markers also have a camera icon next to the left of the nameto easily distinguish them from other informative markers.
The Michigan Historical Commission and staff of the Michigan History Center apply rigorous scholarship and research to ensure that each marker best represents the story it needs to tell. Sponsors raise funds for the manufacture and installation of the markers.
The Commission met over the course of 90 days to enthusiastically debate and discuss monuments and markers on City-owned land. In addition, they heard from thousands of passionate New Yorkers online and in-person. The Commission presents the following Report to the City of New York, including recommendations for general policy and specific existing monuments.
In conclusion, our findings emphasize the potential of microscaled proteogenomic approaches for the investigation of cancer treatment resistance. Follow-up mechanistic studies are clearly warranted, not just for LIG1-related biology but also, for example, the role of lipid-related metabolic signatures in chemotherapy resistance. However, the lack of complete mechanistic insight does not diminish the clinical importance of novel chemotherapy drug-selective predictive biomarkers in a setting where a genomic approach or transcriptomic analyses have yet to produce actionable models.
M. Anurag reports grants from the NIH (U01CA214125 and P50 CA186784-06) during the conduct of the study, as well as a patent for proteogenomic markers of chemotherapy resistance and response in TNBC pending. E.J. Jaehnig reports grants from the NCI and the Cancer Prevention & Research Institute of Texas during the conduct of the study, as well as a patent for proteogenomic markers of chemotherapy resistance and response in TNBC pending. K. Krug reports a patent for Provisional Application No. 63/317,402 pending to the Broad Institute. J.T. Lei reports grants from the NIH during the conduct of the study. D.M. Muzny reports grants from the NIH during the conduct of the study. L.E. Dobrolecki reports grants from Harold & Patricia Korell, a Cancer Prevention & Research Institute of Texas Core Facility Award (RP170691), and NCI-CA125123 P30 Cancer Center Support Grant during the conduct of the study, as well as personal fees from StemMed, Ltd. outside the submitted work. M.T. Lewis reports grants from the NCI and the Cancer Prevention & Research Institute of Texas, and other support from the Korrell family during the conduct of the study, as well as other support from StemMed, Ltd., Tvardi Therapeutics Inc., and StemMed Holdings outside the submitted work. M. Nemati Shafaee reports other support from Eli Lilly, Moderna, AstraZeneca, and Sanofi and grants from Pfizer outside the submitted work. S. Li reports other support from Envigo outside the submitted work. I.S. Hagemann reports personal fees as part of expert witness services and from Change Healthcare outside the submitted work. B. Lim reports consulting fees in the past from Natera, Novartis, Lilly, Pfizer, Puma, AstraZeneca, and Daiichi Sankyo; research funding to conduct trials from Puma, Pfizer, Amgen, Merck, Takeda, Genentech, and Calithera; and honoraria from Prime Oncology and Alpine Oncology. C.K. Osborne reports other support from GeneTex outside the submitted work. D.R. Mani reports grants from the NCI during the conduct of the study. M.A. Gillette reports grants from NIH during the conduct of the study, as well as a pending patent describing proteogenomic methods for diagnosing cancer. B. Zhang reports grants from the NCI and the Cancer Prevention & Research Institute of Texas during the conduct of the study; personal fees from AstraZeneca and TNIK Pharmaceuticals Ltd outside the submitted work; and a patent for proteogenomic markers of chemotherapy resistance and response in TNBC pending. M.F. Rimawi reports grants from Pfizer and personal fees from Macrogenics, Seagen, AstraZeneca, and Novartis outside the submitted work. F.O. Ademuyiwa reports personal fees from Pfizer and Gilead, grants from NeoImmnueTech, Cardinal Health, Biotheranostics, QED, AstraZeneca, and Athenex outside the submitted work. S. Satpathy reports a patent for proteogenomic markers of chemotherapy resistance and response in TNBC pending. M.J. Ellis reports grants from NIH NCI U01214125, NIH NCI P50186784, RR140033, NIH NCI P30 125123, RP210227, and U24CA210954, other support from Lisa and Ralph Eads, and grants and other support from the Korell family during the conduct of the study; personal fees from AstraZeneca outside the submitted work; and a patent for US/094,898 issued and with royalties paid from Veracyte, a patent for CA2,630,974 issued and with royalties paid from Veracyte, a patent for EU06844413.2 issued and with royalties paid from Veracyte, and a patent for U.S. Provisional 63/317,402 pending. No disclosures were reported by the other authors.
Color us impressed! The selection of markers from School Specialty features a vibrant variety of chisel tip, felt tip and fine line marker styles. For your messy, miniature creatives, we offer a wide assortment of washable markers that make clean up a breeze! For teachers who are looking to leave a lasting impression with their lessons, check out our permanent Sharpie, School Smart and Expo marker sets.Markers offer a versatile art and teaching tool that can be used on a variety of mediums. They can also provide hours of entertainment for your coloring book connoisseurs and beginner designers. Add an extra element of engagement with scented markers from beloved brands like Crayola and Mr. Sketch. Whether you need drawing markers for burgeoning artists or teacher-friendly styles for engaging lessons, you can always count on the comprehensive collection of markers from School Specialty.
These morphology markers are commonly used to profile tumor and immune compartments or neuronal populations. These fluorescent dye-conjugated antibodies are validated for a diverse array of tissues and GeoMx assays across mouse and human tissues. These kits are utilized with a SYTO 13 nucleic acid stain kit. The Morphology Kit configuration files are used to auto-populate key target information on the GeoMx scan setup step and can be downloaded here.
The Technology Access Program (TAP) allows users to run small trial projects. Through this work, the program has developed a long list of morphology markers observed to work well with specific tissues under specific conditions. A list of successfully utilized antibodies, RNAscope probes, and the tested tissues has been compiled to help users with their research projects: TAP tested morphology markers
The NanoString user community works with a wide range of morphology markers and tissue types. We are compiling a list of pre-screened markers that worked well with specific tissues by our customers. We encourage our users to share markers that have successfully been used in a GeoMx experiment. Let the research community know by submitting your verified morphology markers via this Community Verified Morphology Markers Form
Pose estimation is of great importance in many computer vision applications: robot navigation, augmented reality, and many more. This process is based on finding correspondences between points in the real environment and their 2d image projection. This is usually a difficult step, and thus it is common to use synthetic or fiducial markers to make it easier. 2ff7e9595c